Sekri Valentin Zerrouk advised AI-Stroke in connection with a $4.6 million funding round led by Newfund
The M&A and Venture Capital Department of Sekri Valentin Zerrouk advised AI-Stroke in connection with a $4.6 million funding round led by Heka, Newfund’s BrainTech fund, with participation from Bpifrance and private investors.
This new financing will enable the company to advance its regulatory pathway with the FDA, launch multi-site clinical studies in the United States with leading stroke centers, and scale the deployment of its ‘AI neurologist,’ capable of detecting signs of stroke in just 30 seconds from any smartphone or tablet.
Team
Other transactions
-
Corporate
Advising the shareholders of M-Work on the sale of the company to the Asys Group
-
Corporate
Advising Geneo Capital on its reinvestment in Leader Group alongside management, to support the acquisition of Mercedes Textiles in Canada and accelerate its international expansion
-
Corporate
Advising Laurent Ruquier on the acquisition of La Comédie des Champs-Élysées and the Studio des Champs-Élysées
-
Corporate
Advising GENEO Capital in connection with its reinvestment in Neftys Pharma
-
Corporate
Advising on the acquisition of Hôtel Piapia, in Paris (20th arrondissement)
-
Real estate law
Advising Edgar Suites on the acquisition, via a share deal, of a site in Vincennes, and the parallel negotiation of a real estate development agreement with SOGEPROM for the development of a new serviced residence
-
Corporate
Advising Santexpat.fr as part of a major acceleration of its growth strategy
-
Corporate
Advising GENEO Capital, Société Générale Capital Partenaires and the founder of Valtus as part of a strategic partnership with Polaris Private Equity
-
Corporate
Advising ClimaNext in connection with the acquisition of GT Ventilation and GT Production (GT Group)
-
Corporate
Advising the management team of Magellan Partners in connection with the arrival of ICG as a new partner